News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
164,949 Results
Type
Article (8911)
Company Profile (43)
Press Release (155987)
Multimedia
Podcasts (33)
Webinars (7)
Section
Business (47439)
Career Advice (282)
Deals (5936)
Drug Delivery (26)
Drug Development (22949)
Employer Resources (42)
FDA (2922)
Job Trends (4001)
News (78970)
Policy (5984)
Tag
Academia (971)
Accelerated approval (8)
Adcomms (4)
Allergies (44)
Alliances (13091)
ALS (65)
Alzheimer's disease (675)
Antibody-drug conjugate (ADC) (96)
Approvals (2967)
Artificial intelligence (188)
Autoimmune disease (46)
Automation (13)
Bankruptcy (36)
Best Places to Work (3534)
BIOSECURE Act (2)
Biosimilars (48)
Biotechnology (24)
Bladder cancer (43)
Brain cancer (19)
Breast cancer (219)
Cancer (1515)
Cardiovascular disease (183)
Career advice (261)
Career pathing (11)
CAR-T (81)
CDC (16)
Cell therapy (233)
Cervical cancer (6)
Clinical research (19086)
Collaboration (599)
Compensation (86)
Complete response letters (14)
COVID-19 (822)
CRISPR (46)
C-suite (330)
Cystic fibrosis (52)
Data (2337)
Denatured (12)
Depression (44)
Diabetes (165)
Diagnostics (1787)
Digital health (9)
Diversity (3)
Diversity, equity & inclusion (12)
Drug discovery (108)
Drug pricing (33)
Drug shortages (3)
Duchenne muscular dystrophy (89)
Earnings (13510)
Editorial (18)
Employer branding (10)
Employer resources (40)
Events (26039)
Executive appointments (359)
FDA (3734)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (1)
Frontotemporal dementia (10)
Funding (523)
Gene editing (84)
Generative AI (16)
Gene therapy (218)
GLP-1 (281)
Government (1126)
Grass and pollen (1)
Guidances (90)
Healthcare (4220)
HIV (28)
Huntington's disease (12)
IgA nephropathy (23)
Immunology and inflammation (54)
Immuno-oncology (18)
Indications (29)
Infectious disease (902)
Inflammatory bowel disease (66)
Inflation Reduction Act (3)
Influenza (37)
Intellectual property (58)
Interviews (39)
IPO (2394)
IRA (10)
Job creations (665)
Job search strategy (232)
JPM (15)
Kidney cancer (2)
Labor market (22)
Layoffs (109)
Leadership (7)
Legal (1011)
Liver cancer (22)
Longevity (6)
Lung cancer (196)
Lymphoma (101)
Machine learning (21)
Management (11)
Manufacturing (203)
MASH (55)
Medical device (1991)
Medtech (2004)
Mergers & acquisitions (3808)
Metabolic disorders (428)
Multiple sclerosis (54)
NASH (5)
Neurodegenerative disease (122)
Neuropsychiatric disorders (27)
Neuroscience (1110)
Neurotech (1)
NextGen: Class of 2026 (1448)
Non-profit (1501)
Now hiring (13)
Obesity (202)
Opinion (75)
Ovarian cancer (43)
Pain (57)
Pancreatic cancer (58)
Parkinson's disease (107)
Partnered (11)
Patents (97)
Patient recruitment (133)
Peanut (14)
People (19790)
Pharmaceutical (9)
Pharmacy benefit managers (1)
Phase 1 (5766)
Phase 2 (8104)
Phase 3 (6615)
Pipeline (1568)
Policy (95)
Postmarket research (705)
Preclinical (3620)
Press Release (33)
Prostate cancer (71)
Psychedelics (18)
Radiopharmaceuticals (64)
Rare diseases (282)
Real estate (1409)
Recruiting (17)
Regulatory (5034)
Reports (9)
Research institute (1097)
Resumes & cover letters (28)
Rett syndrome (8)
RNA editing (5)
RSV (15)
Schizophrenia (42)
Series A (112)
Series B (41)
Sickle cell disease (44)
Special edition (3)
Spinal muscular atrophy (70)
Sponsored (19)
Startups (1256)
State (1)
Stomach cancer (3)
Supply chain (18)
Tariffs (11)
The Weekly (21)
Vaccines (272)
Venture capital (25)
Weight loss (99)
Women's health (29)
Worklife (2)
Date
Last 7 days (164)
Last 30 days (576)
Last 365 days (8776)
2026 (826)
2025 (8742)
2024 (9581)
2023 (10903)
2022 (13893)
2021 (15167)
2020 (13647)
2019 (11381)
2018 (8656)
2017 (8508)
2016 (7978)
2015 (8814)
2014 (6458)
2013 (5155)
2012 (5328)
2011 (5562)
2010 (4667)
Location
Africa (186)
Alabama (22)
Alaska (4)
Arizona (47)
Arkansas (2)
Asia (9506)
Australia (1547)
California (2970)
Canada (961)
China (298)
Colorado (131)
Connecticut (130)
Delaware (93)
Europe (24455)
Florida (366)
Georgia (89)
Hawaii (1)
Idaho (11)
Illinois (181)
India (11)
Indiana (109)
Iowa (5)
Japan (125)
Kansas (20)
Kentucky (6)
Louisiana (10)
Maine (50)
Maryland (362)
Massachusetts (2529)
Michigan (117)
Minnesota (98)
Mississippi (2)
Missouri (38)
Montana (5)
Nebraska (8)
Nevada (27)
New Hampshire (15)
New Jersey (796)
New Mexico (21)
New York (919)
North Carolina (370)
North Dakota (3)
Northern California (1471)
Ohio (102)
Oklahoma (9)
Oregon (23)
Pennsylvania (601)
Puerto Rico (4)
Rhode Island (18)
South America (211)
South Carolina (6)
Southern California (1164)
Tennessee (39)
Texas (490)
United States (10947)
Utah (117)
Vermont (1)
Virginia (66)
Washington D.C. (17)
Washington State (254)
West Virginia (1)
Wisconsin (41)
164,949 Results for "cb scientific".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CB Scientific, Inc. (CBSC) Announces Corporate Name Change to Cardiac Biotech Solutions, Inc.
May 8, 2025
·
4 min read
Press Releases
Skye Bioscience to Present Expanded Preclinical CB1 Antibody Data at the American Diabetes Association’s 85th Scientific Sessions
June 18, 2025
·
4 min read
Press Releases
Corbus Pharmaceuticals Reports Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity Demonstrating Favorable Safety Profile and Emerging Evidence of Weight Loss
December 11, 2025
·
7 min read
Obesity
Skye’s CB1 Inhibitor Shows ‘Intriguing Synergy’ With Wegovy, Despite Mid-Stage Obesity Fail
Skye Bioscience’s nimacimab fell short of investor and company expectations, but showed encouraging weight-loss results when combined with Wegovy, according to analysts at William Blair.
October 7, 2025
·
2 min read
·
Tristan Manalac
Business
CB Scientific, Inc. 2023 Year in Review
CB Scientific. Inc. today is providing its shareholders with a 2023 year-end review from Charles Martin, Chief Executive Officer.
January 11, 2024
·
7 min read
BioMidwest
CB Scientific, Inc. Concludes its Annual Meeting of Stockholders
CB Scientific, Inc., a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring products and services, announced that the company successfully concluded its Annual Meeting of Stockholders on Thursday, March 14, 2024 as planned.
March 19, 2024
·
3 min read
Press Releases
CB Scientific Inc. (CBSC) Formally Launches Next Generation MyCardia AT Cardiac Monitor
February 25, 2025
·
4 min read
Press Releases
Skye Bioscience Shares Nimacimab “Anatomy of Progress” Video Series and Highlights Preclinical CB1 Antibody Data Presented at the American Diabetes Association’s 85th Scientific Sessions
June 23, 2025
·
6 min read
Press Releases
Skye Presents Phase 1b Data for its Peripheral CB1-inhibiting Antibody, Nimacimab, at European Association for the Study of Diabetes (EASD) Annual Meeting
September 22, 2025
·
5 min read
Press Releases
Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak
July 3, 2025
·
13 min read
1 of 16,495
Next
